Recombinant p53 (TP53) protein
Expressed In
Baculovirus
Protein Species
Human
Cat No : 81091,81791 81091
Validation Data Gallery
Product Information
| Expressed In | Baculovirus |
| Protein Species | Human |
Contents
Recombinant p53 (TP53) protein is supplied in 25 mM HEPES-NaOH pH 7.5, 300 mM NaCl, 10% glycerol, 0.04% Triton X-100 and 0.5 mM TCEP.
Background
p53 (TP53) (Tumor Protein P53), also known as Phosphoprotein P53, Transformation-Related Protein 53 or Antigen NY-CO-13, is a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. It involves in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. p53 induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1, thus participating in TP53-dependent transcriptional repression leading to apoptosis and seem to have to effect on cell-cycle regulation. It is required for apoptosis induction, which seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. In cooperation with mitochondrial PPIF, p53 also is involved in activating oxidative stress-induced necrosis, which is largely independent of transcription.
Application Notes
Recombinant p53 (TP53) protein is suitable for use in the study of protein-protein interaction, in vitro transcription assay, binding assay.
Protein Details
Recombinant p53 (TP53) protein was expressed in a baculovirus expression system as the full length protein (accession number NP_000537.3) with an N-terminal FLAG tag. The molecular weight of the protein is 44.9 kDa.
Storage
Recombinant proteins in solution are temperature sensitive and must be stored at -80°C to prevent degradation. Avoid repeated freeze/thaw cycles and keep on ice when not in storage.
Guarantee
This product is guaranteed for 6 months from date of receipt.
This product is for research use only and is not for use in diagnostic procedures.



